NSPR - InspireMD, Inc.

InspireMD, Inc.

4 Menorat Hamaor Street
Tel Aviv 6744832
Israel
972 3 6917691
https://www.inspiremd.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 55

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Marvin L. Slosman	Pres, CEO & Director	696.81k	N/A	1964
Mr. Craig Shore	CFO, Chief Admin. Officer, Sec. & Treasurer	625.24k	N/A	1961
Mr. Andrea Tommasoli	Chief Operating Officer	359.27k	N/A	1972
Mr. Shane Thomas Gleason	GM of North America & VP of Global Marketing	N/A	N/A	1975
Mr. Amir Kohen	VP of Fin. & International HR	N/A	N/A	N/A
Dr. Sol J. Barer Ph.D.	Special Advisor to the Board	N/A	N/A	1947

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Delivery System, a mesh-covered self-expanding carotid stent; SwitchGuard, a non-invasive transcarotid artery revascularization device; and NGuard EPS for treating acute stroke with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Corporate Governance

InspireMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.